1. Home
  2. KROS vs NOA Comparison

KROS vs NOA Comparison

Compare KROS & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • NOA
  • Stock Information
  • Founded
  • KROS 2015
  • NOA 1953
  • Country
  • KROS United States
  • NOA Canada
  • Employees
  • KROS N/A
  • NOA N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • NOA Meat/Poultry/Fish
  • Sector
  • KROS Health Care
  • NOA Consumer Staples
  • Exchange
  • KROS Nasdaq
  • NOA Nasdaq
  • Market Cap
  • KROS 565.0M
  • NOA 478.5M
  • IPO Year
  • KROS 2020
  • NOA 2006
  • Fundamental
  • Price
  • KROS $15.22
  • NOA $15.38
  • Analyst Decision
  • KROS Buy
  • NOA
  • Analyst Count
  • KROS 14
  • NOA 0
  • Target Price
  • KROS $20.56
  • NOA N/A
  • AVG Volume (30 Days)
  • KROS 1.1M
  • NOA 105.0K
  • Earning Date
  • KROS 11-06-2025
  • NOA 11-12-2025
  • Dividend Yield
  • KROS N/A
  • NOA 2.24%
  • EPS Growth
  • KROS N/A
  • NOA N/A
  • EPS
  • KROS 0.47
  • NOA 0.87
  • Revenue
  • KROS $232,844,000.00
  • NOA $919,386,154.00
  • Revenue This Year
  • KROS $6,657.47
  • NOA $12.11
  • Revenue Next Year
  • KROS N/A
  • NOA $6.35
  • P/E Ratio
  • KROS $32.70
  • NOA $17.56
  • Revenue Growth
  • KROS 85820.30
  • NOA 14.15
  • 52 Week Low
  • KROS $9.12
  • NOA $12.12
  • 52 Week High
  • KROS $72.37
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • KROS 49.86
  • NOA 58.91
  • Support Level
  • KROS $14.77
  • NOA $15.13
  • Resistance Level
  • KROS $15.30
  • NOA $15.79
  • Average True Range (ATR)
  • KROS 0.65
  • NOA 0.38
  • MACD
  • KROS 0.02
  • NOA 0.07
  • Stochastic Oscillator
  • KROS 75.17
  • NOA 78.74

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: